Multiple sclerosis: Dubai health body names six risk factors
The Dubai Health Authority (DHA) on World Multiple Sclerosis Day highlighted six factors that may raise the likelihood of developing multiple sclerosis, officials said. Early diagnosis, consistent MS treatment and active family support can significantly improve outcomes and daily functioning for people living with the condition.
The DHA released guidance via its digital platforms, noting the observation applies to residents and reflects broader international evidence on disease patterns and risk factors. Meanwhile, the authority emphasized that awareness and timely care remain central to better long-term management.
Identified risk factors and what they mean
According to the DHA, the six risk factors include being aged between 20 and 40, a higher incidence among women, a family history of the disease, vitamin D deficiency, smoking, and exposure to certain infections. These elements are associated with altered immune responses and environmental exposures that researchers link to demyelinating disorders.
Furthermore, health officials pointed out that vitamin D deficiency has emerged as a modifiable risk factor in multiple sclerosis studies, while smoking and some viral exposures may interact with genetic susceptibility to increase risk. Therefore, public health measures that target smoking cessation and nutritional status could play a preventive role.
Common MS symptoms and clinical overview
Multiple sclerosis is a chronic autoimmune disease of the central nervous system in which the immune system attacks the myelin sheath that insulates nerve fibers, officials stated. Consequently, disruptions occur in nerve signal transmission between the brain, spinal cord and other parts of the body.
MS symptoms vary by lesion location, but the DHA highlighted four primary presentations: weakness or numbness in limbs, balance and walking difficulties, visual or speech disturbances, and severe fatigue. Additionally, patients may experience a range of other neurological signs that fluctuate in intensity from day to day.
Treatment goals, supportive care and family support
While no cure exists for multiple sclerosis, available therapies pursue three main objectives: reduce relapse frequency, slow disease progression and alleviate symptoms, the DHA said. MS treatment today includes disease-modifying therapies, symptomatic treatments and rehabilitation measures to maintain function.
Family support plays a key role in achieving better outcomes, officials added. Positive family involvement helps patients adhere to medication, attend follow-up appointments and adopt healthy habits such as balanced nutrition, regular appropriate physical activity and adequate sleep.
Practical steps for families and caregivers
The DHA outlined six practical actions families can take: learn about the illness and MS symptoms, offer emotional support and attentive listening, encourage adherence to prescribed treatments, assist with scheduling and medication management when needed, promote healthy lifestyle choices, and exercise patience as symptoms vary.
Conversely, the authority warned against three counterproductive practices: downplaying or ignoring symptoms, imposing physical demands beyond the patient’s capacity, and fostering dependence instead of supporting independence. Therefore, caregivers should balance help with respect for the patient’s autonomy.
Public awareness, prevention opportunities and next steps
Officials urged the community to increase awareness about early signs and to support screening and preventive efforts such as addressing vitamin D deficiency and reducing tobacco use. Furthermore, the DHA encouraged clinicians to maintain vigilance for MS in younger adults presenting with neurological complaints.
Research into new therapies and better biomarkers continues internationally, and the authority suggested stakeholders watch for updates on diagnostic protocols and treatment access. Therefore, policymakers and health services are expected to monitor evidence and adjust programs that support people living with MS.
Conclusion and what to watch next
The DHA’s guidance underscores that multiple sclerosis is not an automatic barrier to a productive life when diagnosis, treatment and family support are in place. Moving forward, readers should watch for local initiatives on vitamin D screening, anti-smoking campaigns and expanded access to MS treatment, which the authority indicated could shape outcomes in the months ahead.